Cell line · CVCL_0134

A2780

Cancer cell line, Homo sapiens. Ovarian endometrioid adenocarcinoma. 159 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. A2780. Cell lines, record CVCL_0134. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0134

On this page

Cell line

As Cellosaurus gives it.

Name: A2780
Accession: CVCL_0134
RRID: RRID:CVCL_0134
Synonyms: A-2780, 2780, A2780S, A2780par
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: Age unspecified
Category: Cancer cell line
Diseases: Ovarian endometrioid adenocarcinoma (NCIt C7979); Endometrioid carcinoma of ovary (ORDO Orphanet_454723)
Derived from: Ovary (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers159

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

Paper	Journal	Year	How we know	Source
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.	Oncol Res	2026	Its Methods give the RRID and name the line	PubMed
Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.	J Biochem Mol Toxicol	2026	Its Methods give the RRID and name the line	PubMed
Identifying Drug-Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra.	Bioinorg Chem Appl	2026	Its Methods give the RRID and name the line	PubMed
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity.	Cancer Res Commun	2026	Its Methods give the RRID and name the line	PubMed
A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2/MDM4 axis.	Transl Oncol	2026	Its Methods give the RRID and name the line	PubMed
Fibroblast-derived gremlin-1 Is associated with ovarian cancer-cell phenotypes in co-culture models.	Front Oncol	2026	Its Methods give the RRID and name the line	PubMed
Let-7c-3p Suppresses Ovarian Cancer Progression by Targeting S100A6 and Inhibiting JAK-STAT Signaling.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
HMGB2 Impacts Cisplatin-Induced DNA Adduct Processing in Chemoresistant Ovarian Cancer Cells.	Genes (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.	Cell Rep Methods	2026	Its Methods give the RRID and name the line	PubMed
Malformin A1-mediated cytotoxicity in ovarian cancer cells occurs through pyroptosis and autophagy.	FEBS Open Bio	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 159

See all 159 papers

Relatives45

Relation	Cell line	Accession	Source
Derived from it	2780AD	CVCL_C9BP	Cell lines
Derived from it	A2780 LIN28B KO	CVCL_C3NF	Cell lines
Derived from it	A2780 PTX(4)	CVCL_C0D6	Cell lines
Derived from it	A2780 RRAS2 KO#20	CVCL_E5L2	Cell lines
Derived from it	A2780 RRAS2 KO#3	CVCL_E5L1	Cell lines
Derived from it	A2780-1A9	CVCL_H619	Cell lines
Derived from it	A2780-CBDCA-R	CVCL_ZE22	Cell lines
Derived from it	A2780-DR	CVCL_EG64	Cell lines
Derived from it	A2780-DX1	CVCL_4T95	Cell lines
Derived from it	A2780-M	CVCL_TZ68	Cell lines

1 to 10 of 45

See all 45 relatives

Cell banks10

Cell bank	Catalog number	Status	Source
ABM	T8089		ABM
AddexBio	C0017002/20		Cellosaurus
BCRJ	0031		BCRJ
CLS	300491		CLS
CancerTools	152706		CancerTools
ECACC	93112519	Discontinued	Cellosaurus
Hysigen	TCH-C112		Hysigen
ICLC	HTL98008		ICLC
NCI-DCTD	A2780		Cellosaurus
Ximbio	152706		Ximbio

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0134

GET https://conductscience.org/api/cell-lines/v1/CVCL_0134/papers?page=2

API reference For AI assistants